Status:
NOT_YET_RECRUITING
Effects of CreaSafe® on Kidney, Muscle, and Cardiopulmonary Function in Athletes and COPD Patients
Lead Sponsor:
Federal University of São Paulo
Conditions:
Copd
Athletes
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Creatine supplementation (CS) offers numerous health benefits, with no proven side effects reported to date. CS positively impacts all organs and systems of the body. However, there is an ongoing effo...
Eligibility Criteria
Inclusion
- resistance-trained athletes middle- and long-distance runners severe and/or very severe COPD
Exclusion
- Non-athletes and individuals without a diagnosis of COPD
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT06991426
Start Date
July 1 2025
End Date
October 1 2025
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evangelical University of Goiás
Anápolis, Goiás, Brazil, 75083-515